Lifevantage Corporation Common Stock (Delaware) (LFVN) — Analysis Summary
Lifevantage Corporation Common Stock (Delaware) (LFVN) has a market cap of $75.28M with year-over-year revenue growth of -20.1%. Net margin stands at 2.8%. The stock trades at a P/E ratio of 14.8.
Key Takeaways
- Revenue changed -20.1% year-over-year
- Net margin of 2.8%
- P/E ratio of 14.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, LFVN posted revenue growth of -20.1% and trades at a P/E of 14.8.
Lifevantage Corporation Common Stock (Delaware) (LFVN)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
223
Headquarters
LEHI, UT
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.20
Dividend Yield
3.34%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.